News & Updates

In a prespecified secondary analysis of the SELECT trial, long-term treatment with semaglutide allows more patients with prediabetes to regress to normoglycaemia while reducing progression to diabetes in some patients. However, semaglutide does not slow glycaemic progression over time.

Two new compounds that are set to introduce advancements in the treatment landscape for Alzheimer's disease were approved by the US FDA within 1 month

Use of ticagrelor compared with clopidogrel contributes to a similar risk of major adverse cardiovascular events (MACE) and a higher risk of major bleeding in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), reveals a study.

Older adults with diabetes and hypertension who regularly take their medications tend to have fewer hospitalizations or visits to the emergency room (ER), reports a study.

A prespecified secondary analysis of the Diuretic Comparison Project (DCP) shows that when deciding between chlorthalidone (CTD) and hydrochlorothiazide (HCTZ) for the management of hypertension (HTN), a history of myocardial infarction (MI) or stroke may have to be considered.